Our Products

At Taiho Oncology, all of our efforts are guided by our corporate philosophy: "We strive to improve human health and contribute to a society enriched by smiles." To that end, we are currently researching and developing a number of innovative oral anti-cancer therapies. Please view our Pipeline page to learn more about the investigational products being studied in the United States, and around the world.

We are pleased to announce that on September 22, 2015, we received approval from the U.S. Food and Drug Administration (FDA) for LONSURF® (trifluridine and tipiracil).

To learn more about LONSURF, please visit the links below:


Job description sent to


Event sent to


News Release sent to